We've been holding off fundraising, because we were lucky to receive government grants because of our connections with academia, which lets us gather data throu

We've been holding off fundraising, because we were lucky to receive government grants because of our connections with academia, which lets us gather data through clinical trials, funded by millions of dollars in grant money. This change puts pressure on us — should we raise a seed round so can stay with our bank? Or should we do the science and product discovery right, and then raise? The answer is obvious, but we can't pursue the "obvious" answer because we haven't received equity investment. University accelerators, and even NIH SBIRs apparently don't count?